Androgen receptor (AR) signaling plays a key role in development of Benign prostatic hyperplasia (BPH) and prostate cancer (Shiota et al., 2011; Gioeli and Paschal, 2012; Mills, 2014; Wong et al., 2014; Tan et al., 2015). This evidence concerns the gene AR and prostate carcinoma.